Status:
ACTIVE_NOT_RECRUITING
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
Lead Sponsor:
City of Hope Medical Center
Collaborating Sponsors:
National Institutes of Health (NIH)
National Institute on Aging (NIA)
Conditions:
Breast Cancer
Eligibility:
All Genders
65+ years
Brief Summary
The goal of this study is to develop a "bedside to bench" model of clinical and biological predictors for toxicity to adjuvant and neoadjuvant chemotherapy in older adults with breast cancer. The inve...
Detailed Description
Although cancer is a disease associated with aging, there is no standard tool in oncology practice that incorporates clinical and biological factors to identify older adults with cancer who may be mor...
Eligibility Criteria
Inclusion
- Patients with Breast Cancer:
- Patients with stages I-III breast cancer receiving adjuvant or neoadjuvant chemotherapy
- Able to understand English
- Able to provide informed consent
- Patients age ≥65 and of any performance status are eligible
Exclusion
- Patients with metastatic disease
- Breast Cancer Controls:
- Inclusion Criteria:
- Patients with stages I-III breast cancer
- Patient will not receive adjuvant or neoadjuvant chemotherapy
- Patients age ≥65 and of any performance status are eligible
- Able to understand English
- Able to provide informed consent
Key Trial Info
Start Date :
September 9 2011
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 18 2026
Estimated Enrollment :
700 Patients enrolled
Trial Details
Trial ID
NCT01472094
Start Date
September 9 2011
End Date
September 18 2026
Last Update
November 7 2025
Active Locations (17)
Enter a location and click search to find clinical trials sorted by distance.
1
City of Hope Medical Center
Duarte, California, United States, 91010
2
Yale University
New Haven, Connecticut, United States, 06510
3
University of Chicago
Chicago, Illinois, United States, 60637
4
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114